Zacks Investment Research on MSN
Wave Life Sciences (WVE) Reports Q3 Loss, Misses Revenue Estimates
Wave Life Sciences (WVE) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.3. This compares to a loss of $0.47 per share a year ago. These figures ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results